Roberta Candal de Macedo1, Cristiane Damiani Tomasi1, Vinicius René Giombelli1, Sarah Cascaes Alves1, Maria de Lourdes Ugioni Bristot1, Maria Fernanda Topanotti Locks1, Fabrícia Petronilho2, Carmen Grandi1,3, Joao Quevedo4, Felipe Dal-Pizzol1,3, Cristiane Ritter1,3
ABSTRACT
OBJECTIVE: To evaluate the relationship between brain damage biomarkers and mortality in the intensive care unit (ICU).
METHODS: The sample comprised 70 patients admitted to an ICU. Blood samples were collected from all patients on ICU admission, and levels of S100β and neuron-specific enolase (NSE) were determined by ELISA.
RESULTS: Acute Physiologic and Chronic Health Evaluation (APACHE II) score was associated with mortality, but NSE and S100β were not associated with this outcome. In contrast, S100β levels were significantly higher in delirious and non-delirious patients who required mechanical ventilation during ICU stay.
CONCLUSION: Levels of brain biomarkers at the time of ICU admission did not predict mortality in critically ill patients.
Keywords: Delirium; S100β; enolase; ICU; mortality
THE CONTENT OF THIS ARTICLE IS NOT AVAILABLE FOR THIS LANGUAGE.